

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 9.27137065 |
| 2 | thyroid hormone metabolic process (GO:0042403) | 6.98688495 |
| 3 | adhesion of symbiont to host cell (GO:0044650) | 6.97201429 |
| 4 | virion attachment to host cell (GO:0019062) | 6.97201429 |
| 5 | vitamin A metabolic process (GO:0006776) | 6.49817175 |
| 6 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.38605026 |
| 7 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 6.22732582 |
| 8 | positive regulation of respiratory burst (GO:0060267) | 6.19153316 |
| 9 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.07299208 |
| 10 | adhesion of symbiont to host (GO:0044406) | 5.72374439 |
| 11 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.69387370 |
| 12 | actin filament depolymerization (GO:0030042) | 5.63306905 |
| 13 | thyroid hormone generation (GO:0006590) | 5.62170941 |
| 14 | digestive system process (GO:0022600) | 5.56614171 |
| 15 | complement activation, classical pathway (GO:0006958) | 5.52889619 |
| 16 | hemidesmosome assembly (GO:0031581) | 5.22251739 |
| 17 | drug catabolic process (GO:0042737) | 5.16493410 |
| 18 | antibacterial humoral response (GO:0019731) | 5.08258733 |
| 19 | modified amino acid transport (GO:0072337) | 5.02088286 |
| 20 | antimicrobial humoral response (GO:0019730) | 4.97764282 |
| 21 | hydrogen peroxide catabolic process (GO:0042744) | 4.95713652 |
| 22 | glutathione biosynthetic process (GO:0006750) | 4.86673248 |
| 23 | bile acid and bile salt transport (GO:0015721) | 4.70173906 |
| 24 | regulation of bile acid biosynthetic process (GO:0070857) | 4.66296868 |
| 25 | complement activation (GO:0006956) | 4.63092563 |
| 26 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.58468272 |
| 27 | regulation of metalloenzyme activity (GO:0048552) | 4.55447709 |
| 28 | regulation of cellular extravasation (GO:0002691) | 4.54832026 |
| 29 | flavonoid metabolic process (GO:0009812) | 4.54237007 |
| 30 | intestinal epithelial cell development (GO:0060576) | 4.53772556 |
| 31 | regulation of RIG-I signaling pathway (GO:0039535) | 4.53635933 |
| 32 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.52813284 |
| 33 | acute-phase response (GO:0006953) | 4.48297709 |
| 34 | long term synaptic depression (GO:0060292) | 4.36032871 |
| 35 | drinking behavior (GO:0042756) | 4.35026680 |
| 36 | epithelial structure maintenance (GO:0010669) | 4.30941464 |
| 37 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.29051957 |
| 38 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.29051957 |
| 39 | diacylglycerol metabolic process (GO:0046339) | 4.28809392 |
| 40 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.16386848 |
| 41 | tetrapyrrole metabolic process (GO:0033013) | 4.05652829 |
| 42 | phospholipid efflux (GO:0033700) | 4.05370032 |
| 43 | regulation of cholesterol esterification (GO:0010872) | 4.02445808 |
| 44 | regulation of respiratory burst (GO:0060263) | 3.99033513 |
| 45 | glucose 6-phosphate metabolic process (GO:0051156) | 3.98097694 |
| 46 | O-glycan processing (GO:0016266) | 3.96805204 |
| 47 | hepatocyte apoptotic process (GO:0097284) | 3.94809782 |
| 48 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.90977387 |
| 49 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.90977387 |
| 50 | regulation of viral release from host cell (GO:1902186) | 3.89825295 |
| 51 | sulfation (GO:0051923) | 3.89010659 |
| 52 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.88977143 |
| 53 | glomerular filtration (GO:0003094) | 3.88314229 |
| 54 | plasma lipoprotein particle assembly (GO:0034377) | 3.87063496 |
| 55 | protein-lipid complex assembly (GO:0065005) | 3.82634904 |
| 56 | response to hepatocyte growth factor (GO:0035728) | 3.81632964 |
| 57 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.81632964 |
| 58 | sulfate transmembrane transport (GO:1902358) | 3.81462441 |
| 59 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.80062397 |
| 60 | lipoprotein metabolic process (GO:0042157) | 3.78094884 |
| 61 | sulfur compound transport (GO:0072348) | 3.76926564 |
| 62 | acute inflammatory response (GO:0002526) | 3.76384166 |
| 63 | digestion (GO:0007586) | 3.73868300 |
| 64 | regulation of interleukin-8 secretion (GO:2000482) | 3.73649444 |
| 65 | purine nucleotide salvage (GO:0032261) | 3.71735416 |
| 66 | regulation of triglyceride catabolic process (GO:0010896) | 3.71709907 |
| 67 | defense response to fungus (GO:0050832) | 3.69016597 |
| 68 | cGMP-mediated signaling (GO:0019934) | 3.67670087 |
| 69 | leukotriene biosynthetic process (GO:0019370) | 3.67409798 |
| 70 | protein activation cascade (GO:0072376) | 3.67332151 |
| 71 | renal filtration (GO:0097205) | 3.62012072 |
| 72 | * hydrogen peroxide metabolic process (GO:0042743) | 3.61680192 |
| 73 | peptide biosynthetic process (GO:0043043) | 3.57452209 |
| 74 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.55524871 |
| 75 | regulation of complement activation (GO:0030449) | 3.53771901 |
| 76 | transcytosis (GO:0045056) | 3.53687312 |
| 77 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.53516033 |
| 78 | complement activation, alternative pathway (GO:0006957) | 3.53313515 |
| 79 | glutathione derivative metabolic process (GO:1901685) | 3.53186843 |
| 80 | glutathione derivative biosynthetic process (GO:1901687) | 3.53186843 |
| 81 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 3.52726374 |
| 82 | regulation of protein activation cascade (GO:2000257) | 3.48914620 |
| 83 | positive regulation of pseudopodium assembly (GO:0031274) | 3.44907295 |
| 84 | peptide hormone processing (GO:0016486) | 3.44292667 |
| 85 | disruption of cells of other organism (GO:0044364) | 3.42500324 |
| 86 | killing of cells of other organism (GO:0031640) | 3.42500324 |
| 87 | negative regulation of sterol transport (GO:0032372) | 3.41463203 |
| 88 | negative regulation of cholesterol transport (GO:0032375) | 3.41463203 |
| 89 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.41074989 |
| 90 | response to laminar fluid shear stress (GO:0034616) | 3.40300459 |
| 91 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.40021252 |
| 92 | arginine catabolic process (GO:0006527) | 3.38645006 |
| 93 | cholesterol efflux (GO:0033344) | 3.38015386 |
| 94 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.37290935 |
| 95 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.33952064 |
| 96 | regulation of acrosome reaction (GO:0060046) | 3.32843482 |
| 97 | glycerophospholipid catabolic process (GO:0046475) | 3.32153210 |
| 98 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.30359532 |
| 99 | water-soluble vitamin metabolic process (GO:0006767) | 3.25207155 |
| 100 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.23092654 |
| 101 | regulation of cholesterol homeostasis (GO:2000188) | 3.21898185 |
| 102 | chronic inflammatory response (GO:0002544) | 3.18963639 |
| 103 | innate immune response in mucosa (GO:0002227) | 3.18750523 |
| 104 | cholesterol homeostasis (GO:0042632) | 3.17308029 |
| 105 | sterol homeostasis (GO:0055092) | 3.17196247 |
| 106 | cellular response to fluid shear stress (GO:0071498) | 3.16444919 |
| 107 | sterol transport (GO:0015918) | 3.15826747 |
| 108 | cholesterol transport (GO:0030301) | 3.15826747 |
| 109 | hypotonic response (GO:0006971) | 3.15104219 |
| 110 | oligosaccharide biosynthetic process (GO:0009312) | 3.14356434 |
| 111 | thyroid gland development (GO:0030878) | 3.13671309 |
| 112 | parturition (GO:0007567) | 3.12325342 |
| 113 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.09865301 |
| 114 | regulation of pseudopodium assembly (GO:0031272) | 3.08336101 |
| 115 | sulfate transport (GO:0008272) | 3.07810141 |
| 116 | protein neddylation (GO:0045116) | 3.07535677 |
| 117 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.07068341 |
| 118 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.06277771 |
| 119 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.05413184 |
| 120 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.05080434 |
| 121 | response to hydroperoxide (GO:0033194) | 3.04969624 |
| 122 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.01453196 |
| 123 | negative regulation of hormone metabolic process (GO:0032351) | 3.01453196 |
| 124 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.00713797 |
| 125 | cysteine metabolic process (GO:0006534) | 3.00270116 |
| 126 | transepithelial transport (GO:0070633) | 2.99591179 |
| 127 | glucuronate metabolic process (GO:0019585) | 2.99242209 |
| 128 | uronic acid metabolic process (GO:0006063) | 2.99242209 |
| 129 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176) | 2.97989409 |
| 130 | peptide catabolic process (GO:0043171) | 2.95583614 |
| 131 | neutral amino acid transport (GO:0015804) | 2.95522654 |
| 132 | L-fucose catabolic process (GO:0042355) | 2.93514907 |
| 133 | fucose catabolic process (GO:0019317) | 2.93514907 |
| 134 | L-fucose metabolic process (GO:0042354) | 2.93514907 |
| 135 | peroxisome fission (GO:0016559) | 2.93400165 |
| 136 | adenosine metabolic process (GO:0046085) | 2.93319016 |
| 137 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.92363886 |
| 138 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.89188520 |
| 139 | regulation of substrate adhesion-dependent cell spreading (GO:1900024) | 2.88601654 |
| 140 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.88506893 |
| 141 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.87152840 |
| 142 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.87133728 |
| 143 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.87133728 |
| 144 | endocrine process (GO:0050886) | 2.87133728 |
| 145 | protein autoprocessing (GO:0016540) | 2.86610517 |
| 146 | reverse cholesterol transport (GO:0043691) | 2.83296458 |
| 147 | leukotriene metabolic process (GO:0006691) | 2.82530672 |
| 148 | desmosome organization (GO:0002934) | 2.82258017 |
| 149 | regulation of guanylate cyclase activity (GO:0031282) | 2.82192008 |
| 150 | lipoprotein transport (GO:0042953) | 2.82187927 |
| 151 | regulation of proton transport (GO:0010155) | 2.80957644 |
| 152 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.80609226 |
| 153 | negative regulation of protein activation cascade (GO:2000258) | 2.80089023 |
| 154 | extracellular matrix disassembly (GO:0022617) | 2.80059974 |
| 155 | regulation of actin nucleation (GO:0051125) | 2.79516753 |
| 156 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.79270753 |
| 157 | mucosal immune response (GO:0002385) | 2.79008356 |
| 158 | fucosylation (GO:0036065) | 2.78633656 |
| 159 | glutathione metabolic process (GO:0006749) | 2.76184269 |
| 160 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.75421198 |
| 161 | hormone catabolic process (GO:0042447) | 2.73684572 |
| 162 | vitamin metabolic process (GO:0006766) | 2.73375582 |
| 163 | retinol metabolic process (GO:0042572) | 2.68860403 |
| 164 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.68078134 |
| 165 | regulation of apoptotic cell clearance (GO:2000425) | 2.65033532 |
| 166 | arginine metabolic process (GO:0006525) | 2.62641497 |
| 167 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.60835052 |
| 168 | positive regulation of glomerulus development (GO:0090193) | 2.59991150 |
| 169 | regulation of mononuclear cell migration (GO:0071675) | 2.58048375 |
| 170 | phosphatidylserine metabolic process (GO:0006658) | 2.57556277 |
| 171 | humoral immune response (GO:0006959) | 2.57144441 |
| 172 | regulation of calcium ion import (GO:0090279) | 2.54345410 |
| 173 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.53577729 |
| 174 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.52249544 |
| 175 | positive regulation of extracellular matrix organization (GO:1903055) | 2.50838152 |
| 176 | endocrine pancreas development (GO:0031018) | 2.49673964 |
| 177 | cobalamin metabolic process (GO:0009235) | 11.9697715 |
| 178 | intestinal absorption (GO:0050892) | 11.1648949 |
| 179 | intestinal cholesterol absorption (GO:0030299) | 10.3755204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 9.40856465 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.95149719 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.36923850 |
| 4 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.34805349 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.14989858 |
| 6 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.05965256 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.00130474 |
| 8 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.74961592 |
| 9 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.69730931 |
| 10 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.62853056 |
| 11 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.39087608 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.35335862 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.22451950 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.18349095 |
| 15 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.08848254 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.05654732 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.02321856 |
| 18 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.02091397 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.96957169 |
| 20 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.96667062 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.91520376 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.90363762 |
| 23 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.85285464 |
| 24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.84423125 |
| 25 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.83057340 |
| 26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.81003623 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.72661247 |
| 28 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72258002 |
| 29 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.70062152 |
| 30 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.68884489 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66145831 |
| 32 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.65572797 |
| 33 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.65372190 |
| 34 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.65240476 |
| 35 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.61162256 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.60412542 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.57644947 |
| 38 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56323293 |
| 39 | ATF3_27146783_Chip-Seq_COLON_Human | 1.54954954 |
| 40 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50495452 |
| 41 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46617130 |
| 42 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.44444161 |
| 43 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.43330991 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.39280724 |
| 45 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39091493 |
| 46 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.37280029 |
| 47 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.35686368 |
| 48 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.35636529 |
| 49 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.30012360 |
| 50 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.29060037 |
| 51 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.27364582 |
| 52 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27233827 |
| 53 | GATA2_19941826_ChIP-Seq_K562_Human | 1.26207181 |
| 54 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25436377 |
| 55 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24682970 |
| 56 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.22921790 |
| 57 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.22921790 |
| 58 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.20712321 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19848275 |
| 60 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19535659 |
| 61 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.18399549 |
| 62 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.15593199 |
| 63 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.15496353 |
| 64 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14818767 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14013237 |
| 66 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13489666 |
| 67 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.09903462 |
| 68 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08626516 |
| 69 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07949805 |
| 70 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07835228 |
| 71 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.06693248 |
| 72 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.04514400 |
| 73 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.04490661 |
| 74 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.04356123 |
| 75 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.03724883 |
| 76 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02514708 |
| 77 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98860423 |
| 78 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98747593 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97040009 |
| 80 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.95178297 |
| 81 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95056466 |
| 82 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94661855 |
| 83 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.94373579 |
| 84 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.94014202 |
| 85 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93966983 |
| 86 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.93130980 |
| 87 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91478017 |
| 88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89912897 |
| 89 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.89766473 |
| 90 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.89129905 |
| 91 | CJUN_26792858_Chip-Seq_BT549_Human | 0.88683314 |
| 92 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88671705 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87406596 |
| 94 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.87106370 |
| 95 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86762707 |
| 96 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.86703698 |
| 97 | ERA_21632823_ChIP-Seq_H3396_Human | 0.86506278 |
| 98 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.86029807 |
| 99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85649838 |
| 100 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.85038844 |
| 101 | P300_27268052_Chip-Seq_Bcells_Human | 0.84129565 |
| 102 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83999768 |
| 103 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.83868568 |
| 104 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.83836779 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83766041 |
| 106 | SA1_27219007_Chip-Seq_Bcells_Human | 0.83686775 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83304598 |
| 108 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.83086954 |
| 109 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82378844 |
| 110 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.82183713 |
| 111 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81740983 |
| 112 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.81053350 |
| 113 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81024514 |
| 114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81000754 |
| 115 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79789626 |
| 116 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.79367221 |
| 117 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.78879576 |
| 118 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.78847250 |
| 119 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.78608996 |
| 120 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.78374529 |
| 121 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.77827654 |
| 122 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.77406667 |
| 123 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.76274396 |
| 124 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.76048337 |
| 125 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.74855161 |
| 126 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74797690 |
| 127 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.74747596 |
| 128 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.74499207 |
| 129 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.73465313 |
| 130 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72598343 |
| 131 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.72542483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.40858398 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 5.33048166 |
| 3 | MP0001666_abnormal_nutrient_absorption | 5.18460990 |
| 4 | MP0005083_abnormal_biliary_tract | 4.46362937 |
| 5 | MP0004264_abnormal_extraembryonic_tissu | 4.40406543 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 3.88651473 |
| 7 | MP0003183_abnormal_peptide_metabolism | 3.64672768 |
| 8 | MP0000462_abnormal_digestive_system | 3.35852799 |
| 9 | MP0002876_abnormal_thyroid_physiology | 3.33065941 |
| 10 | MP0009840_abnormal_foam_cell | 3.29067978 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.97980943 |
| 12 | MP0000537_abnormal_urethra_morphology | 2.85310137 |
| 13 | MP0010386_abnormal_urinary_bladder | 2.68690622 |
| 14 | MP0003866_abnormal_defecation | 2.58845347 |
| 15 | MP0003252_abnormal_bile_duct | 2.58116139 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 2.54643492 |
| 17 | MP0000538_abnormal_urinary_bladder | 2.24723789 |
| 18 | MP0003724_increased_susceptibility_to | 2.20185161 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.00795926 |
| 20 | MP0003011_delayed_dark_adaptation | 1.94608738 |
| 21 | MP0001664_abnormal_digestion | 1.93237893 |
| 22 | MP0010155_abnormal_intestine_physiology | 1.93170524 |
| 23 | MP0005381_digestive/alimentary_phenotyp | 1.92367352 |
| 24 | MP0001663_abnormal_digestive_system | 1.87573764 |
| 25 | MP0001756_abnormal_urination | 1.84822836 |
| 26 | MP0004147_increased_porphyrin_level | 1.80675137 |
| 27 | MP0001873_stomach_inflammation | 1.74566203 |
| 28 | MP0005084_abnormal_gallbladder_morpholo | 1.71592616 |
| 29 | MP0001849_ear_inflammation | 1.70397166 |
| 30 | MP0003436_decreased_susceptibility_to | 1.69698028 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 1.68749376 |
| 32 | MP0005365_abnormal_bile_salt | 1.67654643 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.67210334 |
| 34 | MP0000477_abnormal_intestine_morphology | 1.62016430 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.61379164 |
| 36 | MP0008875_abnormal_xenobiotic_pharmacok | 1.54921165 |
| 37 | MP0006054_spinal_hemorrhage | 1.50911658 |
| 38 | MP0010678_abnormal_skin_adnexa | 1.50443850 |
| 39 | MP0004019_abnormal_vitamin_homeostasis | 1.48742271 |
| 40 | MP0003075_altered_response_to | 1.44253970 |
| 41 | MP0002132_abnormal_respiratory_system | 1.41729900 |
| 42 | MP0008004_abnormal_stomach_pH | 1.41556597 |
| 43 | MP0000490_abnormal_crypts_of | 1.39348306 |
| 44 | MP0002796_impaired_skin_barrier | 1.35967379 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.33096036 |
| 46 | MP0000685_abnormal_immune_system | 1.31737652 |
| 47 | MP0005451_abnormal_body_composition | 1.30550872 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.28344268 |
| 49 | MP0005377_hearing/vestibular/ear_phenot | 1.26901646 |
| 50 | MP0003878_abnormal_ear_physiology | 1.26901646 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.23579852 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 1.23084937 |
| 53 | MP0001790_abnormal_immune_system | 1.21141012 |
| 54 | MP0005387_immune_system_phenotype | 1.21141012 |
| 55 | MP0009379_abnormal_foot_pigmentation | 1.19322059 |
| 56 | MP0000681_abnormal_thyroid_gland | 1.13807055 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.13410248 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.12065813 |
| 59 | MP0003195_calcinosis | 1.11854991 |
| 60 | MP0009643_abnormal_urine_homeostasis | 1.09242881 |
| 61 | MP0005025_abnormal_response_to | 1.09229909 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.07682824 |
| 63 | MP0003186_abnormal_redox_activity | 1.05450135 |
| 64 | MP0003938_abnormal_ear_development | 1.04344753 |
| 65 | MP0004947_skin_inflammation | 1.03864505 |
| 66 | MP0005220_abnormal_exocrine_pancreas | 1.03400196 |
| 67 | MP0005448_abnormal_energy_balance | 1.02384105 |
| 68 | MP0004043_abnormal_pH_regulation | 1.01755753 |
| 69 | MP0003191_abnormal_cellular_cholesterol | 1.01258274 |
| 70 | MP0002822_catalepsy | 1.00912388 |
| 71 | MP0005501_abnormal_skin_physiology | 0.99173540 |
| 72 | MP0002163_abnormal_gland_morphology | 0.97475280 |
| 73 | MP0008469_abnormal_protein_level | 0.96600070 |
| 74 | MP0000516_abnormal_urinary_system | 0.96250008 |
| 75 | MP0005367_renal/urinary_system_phenotyp | 0.96250008 |
| 76 | MP0005332_abnormal_amino_acid | 0.95213418 |
| 77 | MP0009697_abnormal_copulation | 0.95028677 |
| 78 | MP0003315_abnormal_perineum_morphology | 0.94988481 |
| 79 | MP0001845_abnormal_inflammatory_respons | 0.93694196 |
| 80 | MP0003283_abnormal_digestive_organ | 0.93629153 |
| 81 | MP0002006_tumorigenesis | 0.93188997 |
| 82 | MP0005166_decreased_susceptibility_to | 0.92875892 |
| 83 | MP0001764_abnormal_homeostasis | 0.90972379 |
| 84 | MP0003718_maternal_effect | 0.90471090 |
| 85 | MP0002254_reproductive_system_inflammat | 0.89690840 |
| 86 | MP0001216_abnormal_epidermal_layer | 0.89634762 |
| 87 | MP0005310_abnormal_salivary_gland | 0.85894372 |
| 88 | MP0001661_extended_life_span | 0.85676988 |
| 89 | MP0002148_abnormal_hypersensitivity_rea | 0.83991605 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.83770542 |
| 91 | MP0000470_abnormal_stomach_morphology | 0.82779419 |
| 92 | MP0000609_abnormal_liver_physiology | 0.82714809 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 0.82560276 |
| 94 | MP0000467_abnormal_esophagus_morphology | 0.82082396 |
| 95 | MP0003329_amyloid_beta_deposits | 0.81880607 |
| 96 | MP0000604_amyloidosis | 0.80552001 |
| 97 | MP0005248_abnormal_Harderian_gland | 0.80333949 |
| 98 | MP0001765_abnormal_ion_homeostasis | 0.79556875 |
| 99 | MP0000613_abnormal_salivary_gland | 0.79095140 |
| 100 | MP0002098_abnormal_vibrissa_morphology | 0.78182249 |
| 101 | MP0002089_abnormal_postnatal_growth/wei | 0.77143595 |
| 102 | MP0002118_abnormal_lipid_homeostasis | 0.76229578 |
| 103 | MP0010307_abnormal_tumor_latency | 0.74107160 |
| 104 | MP0000343_altered_response_to | 0.73902788 |
| 105 | MP0004270_analgesia | 0.73458235 |
| 106 | MP0001501_abnormal_sleep_pattern | 0.73273992 |
| 107 | MP0000249_abnormal_blood_vessel | 0.70185178 |
| 108 | MP0002060_abnormal_skin_morphology | 0.67737904 |
| 109 | MP0003045_fibrosis | 0.67653571 |
| 110 | MP0005058_abnormal_lysosome_morphology | 0.67488130 |
| 111 | MP0005464_abnormal_platelet_physiology | 0.67478940 |
| 112 | MP0002136_abnormal_kidney_physiology | 0.67414759 |
| 113 | MP0008775_abnormal_heart_ventricle | 0.67045278 |
| 114 | MP0004782_abnormal_surfactant_physiolog | 0.64805603 |
| 115 | MP0009780_abnormal_chondrocyte_physiolo | 0.64503606 |
| 116 | MP0005164_abnormal_response_to | 0.64242212 |
| 117 | MP0005187_abnormal_penis_morphology | 0.63187987 |
| 118 | MP0003448_altered_tumor_morphology | 0.63183821 |
| 119 | MP0001800_abnormal_humoral_immune | 0.63129258 |
| 120 | MP0005670_abnormal_white_adipose | 0.62489569 |
| 121 | MP0003953_abnormal_hormone_level | 0.62457619 |
| 122 | MP0005023_abnormal_wound_healing | 0.60269887 |
| 123 | MP0000383_abnormal_hair_follicle | 0.59898515 |
| 124 | MP0008872_abnormal_physiological_respon | 0.59476853 |
| 125 | MP0005636_abnormal_mineral_homeostasis | 0.59199136 |
| 126 | MP0003950_abnormal_plasma_membrane | 0.58832235 |
| 127 | MP0004858_abnormal_nervous_system | 0.58006940 |
| 128 | MP0000579_abnormal_nail_morphology | 0.56864342 |
| 129 | MP0001881_abnormal_mammary_gland | 0.56232203 |
| 130 | MP0010771_integument_phenotype | 0.55213405 |
| 131 | MP0003879_abnormal_hair_cell | 0.54967603 |
| 132 | MP0005319_abnormal_enzyme/_coenzyme | 0.54805036 |
| 133 | MP0003868_abnormal_feces_composition | 0.53619666 |
| 134 | MP0009053_abnormal_anal_canal | 0.53310388 |
| 135 | MP0005266_abnormal_metabolism | 0.52632421 |
| 136 | MP0009384_cardiac_valve_regurgitation | 0.51946812 |
| 137 | MP0009785_altered_susceptibility_to | 0.48078811 |
| 138 | MP0009642_abnormal_blood_homeostasis | 0.47531159 |
| 139 | MP0000377_abnormal_hair_follicle | 0.45546225 |
| 140 | MP0006138_congestive_heart_failure | 0.44645446 |
| 141 | MP0003693_abnormal_embryo_hatching | 0.44253071 |
| 142 | MP0005165_increased_susceptibility_to | 0.44037757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steatorrhea (HP:0002570) | 7.98238943 |
| 2 | Exocrine pancreatic insufficiency (HP:0001738) | 7.72561010 |
| 3 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 7.59482697 |
| 4 | Right ventricular cardiomyopathy (HP:0011663) | 6.98797810 |
| 5 | Ileus (HP:0002595) | 6.90690333 |
| 6 | Hydroxyprolinuria (HP:0003080) | 5.95092775 |
| 7 | Abnormality of proline metabolism (HP:0010907) | 5.95092775 |
| 8 | Hypoproteinemia (HP:0003075) | 5.61663527 |
| 9 | Gout (HP:0001997) | 5.53141758 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 5.32361546 |
| 11 | Onycholysis (HP:0001806) | 5.24073454 |
| 12 | Malnutrition (HP:0004395) | 4.72520615 |
| 13 | Milia (HP:0001056) | 4.68665216 |
| 14 | Cupped ribs (HP:0000887) | 4.42976809 |
| 15 | Glomerulonephritis (HP:0000099) | 4.36561205 |
| 16 | Fragile nails (HP:0001808) | 4.33107244 |
| 17 | Pustule (HP:0200039) | 4.27351160 |
| 18 | Acanthocytosis (HP:0001927) | 4.25011680 |
| 19 | Atrophic scars (HP:0001075) | 4.21472035 |
| 20 | Hyperuricemia (HP:0002149) | 4.06823610 |
| 21 | Increased purine levels (HP:0004368) | 4.06823610 |
| 22 | Hypobetalipoproteinemia (HP:0003563) | 3.97774152 |
| 23 | Chronic diarrhea (HP:0002028) | 3.92933756 |
| 24 | Autoimmune hemolytic anemia (HP:0001890) | 3.85099787 |
| 25 | Conjugated hyperbilirubinemia (HP:0002908) | 3.79025340 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 3.72239472 |
| 27 | Tubulointerstitial nephritis (HP:0001970) | 3.70811936 |
| 28 | Complement deficiency (HP:0004431) | 3.60236617 |
| 29 | Pancreatitis (HP:0001733) | 3.55563674 |
| 30 | Abdominal distention (HP:0003270) | 3.54820072 |
| 31 | * Goiter (HP:0000853) | 3.53084103 |
| 32 | Mesangial abnormality (HP:0001966) | 3.47826814 |
| 33 | Abnormality of the 1st metacarpal (HP:0010009) | 3.29838575 |
| 34 | Hyperglycinuria (HP:0003108) | 3.23527587 |
| 35 | Increased IgE level (HP:0003212) | 3.22979506 |
| 36 | Plantar hyperkeratosis (HP:0007556) | 3.13746624 |
| 37 | Abnormality of complement system (HP:0005339) | 3.13365895 |
| 38 | Fat malabsorption (HP:0002630) | 3.08951895 |
| 39 | Pili torti (HP:0003777) | 3.02785209 |
| 40 | Woolly hair (HP:0002224) | 2.95279904 |
| 41 | Renal salt wasting (HP:0000127) | 2.94744598 |
| 42 | Palpitations (HP:0001962) | 2.91529698 |
| 43 | Poikilocytosis (HP:0004447) | 2.86028150 |
| 44 | Dehydration (HP:0001944) | 2.83178425 |
| 45 | Stridor (HP:0010307) | 2.82490777 |
| 46 | Micronodular cirrhosis (HP:0001413) | 2.82265506 |
| 47 | Villous atrophy (HP:0011473) | 2.78102660 |
| 48 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.78102660 |
| 49 | Nephritis (HP:0000123) | 2.73412185 |
| 50 | Myopathic facies (HP:0002058) | 2.73152109 |
| 51 | Abnormal tarsal ossification (HP:0008369) | 2.72359099 |
| 52 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.70422531 |
| 53 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.69972579 |
| 54 | Pigmentary retinal degeneration (HP:0001146) | 2.65997986 |
| 55 | B lymphocytopenia (HP:0010976) | 2.65187469 |
| 56 | Abnormality of B cell number (HP:0010975) | 2.65187469 |
| 57 | Hypoglycemic coma (HP:0001325) | 2.65090201 |
| 58 | Hypolipoproteinemia (HP:0010981) | 2.64647962 |
| 59 | Hand muscle atrophy (HP:0009130) | 2.63316089 |
| 60 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.62540418 |
| 61 | Gastrointestinal dysmotility (HP:0002579) | 2.62296089 |
| 62 | Spinal muscular atrophy (HP:0007269) | 2.59524358 |
| 63 | Abnormality of the gastric mucosa (HP:0004295) | 2.58801695 |
| 64 | Barrel-shaped chest (HP:0001552) | 2.58308034 |
| 65 | Flat acetabular roof (HP:0003180) | 2.57912870 |
| 66 | Syncope (HP:0001279) | 2.57430765 |
| 67 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.56826569 |
| 68 | Ureteral stenosis (HP:0000071) | 2.55542247 |
| 69 | Diaphragmatic weakness (HP:0009113) | 2.54865519 |
| 70 | Distal lower limb muscle weakness (HP:0009053) | 2.52701437 |
| 71 | Cheilitis (HP:0100825) | 2.52636925 |
| 72 | Abnormal glucose tolerance (HP:0001952) | 2.50527987 |
| 73 | Increased serum pyruvate (HP:0003542) | 2.49010662 |
| 74 | Tubulointerstitial fibrosis (HP:0005576) | 2.48335817 |
| 75 | Abnormality of nucleobase metabolism (HP:0010932) | 2.47250078 |
| 76 | Abnormal pancreas size (HP:0012094) | 2.46603592 |
| 77 | Late onset (HP:0003584) | 2.45794923 |
| 78 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.44678992 |
| 79 | Disproportionate short-trunk short stature (HP:0003521) | 2.44551816 |
| 80 | Abnormality of chloride homeostasis (HP:0011422) | 2.44319189 |
| 81 | Abnormality of the pleura (HP:0002103) | 2.42078733 |
| 82 | Glomerulosclerosis (HP:0000096) | 2.40684530 |
| 83 | Ureteral obstruction (HP:0006000) | 2.39636420 |
| 84 | Glucose intolerance (HP:0000833) | 2.39092779 |
| 85 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.38388583 |
| 86 | Biliary tract neoplasm (HP:0100574) | 2.37846909 |
| 87 | Rough bone trabeculation (HP:0100670) | 2.37737065 |
| 88 | Abnormality of urine glucose concentration (HP:0011016) | 2.37275450 |
| 89 | Glycosuria (HP:0003076) | 2.37275450 |
| 90 | Vascular calcification (HP:0004934) | 2.37110870 |
| 91 | Curly hair (HP:0002212) | 2.33498002 |
| 92 | Abnormal biliary tract morphology (HP:0012440) | 2.31275399 |
| 93 | Upper limb amyotrophy (HP:0009129) | 2.31271329 |
| 94 | Distal upper limb amyotrophy (HP:0007149) | 2.31271329 |
| 95 | Hypoplasia of dental enamel (HP:0006297) | 2.31021474 |
| 96 | Amyloidosis (HP:0011034) | 2.28898670 |
| 97 | Reticulocytosis (HP:0001923) | 2.28572264 |
| 98 | Intrahepatic cholestasis (HP:0001406) | 2.28551759 |
| 99 | Abnormality of purine metabolism (HP:0004352) | 2.26608243 |
| 100 | Progressive sensorineural hearing impairment (HP:0000408) | 2.25600406 |
| 101 | Abnormality of vitamin B metabolism (HP:0004340) | 2.25566030 |
| 102 | Ventricular tachycardia (HP:0004756) | 2.25205598 |
| 103 | Fragile skin (HP:0001030) | 2.24579631 |
| 104 | Cervical subluxation (HP:0003308) | 2.24403604 |
| 105 | Hyperactive renin-angiotensin system (HP:0000841) | 2.24349958 |
| 106 | Nephrolithiasis (HP:0000787) | 2.23637065 |
| 107 | Spontaneous abortion (HP:0005268) | 2.23136955 |
| 108 | Abnormality of glycolysis (HP:0004366) | 2.20636343 |
| 109 | Congenital, generalized hypertrichosis (HP:0004540) | 2.20135532 |
| 110 | Abnormal hair laboratory examination (HP:0003328) | 2.20067222 |
| 111 | Increased mean platelet volume (HP:0011877) | 2.19925181 |
| 112 | Severe combined immunodeficiency (HP:0004430) | 2.19750337 |
| 113 | Large for gestational age (HP:0001520) | 2.15477405 |
| 114 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.15295059 |
| 115 | Alopecia of scalp (HP:0002293) | 2.13089273 |
| 116 | Cardiovascular calcification (HP:0011915) | 2.12885844 |
| 117 | Short phalanx of the thumb (HP:0009660) | 2.12574511 |
| 118 | Abnormality of carpal bone ossification (HP:0006257) | 2.11561399 |
| 119 | Combined immunodeficiency (HP:0005387) | 2.10707714 |
| 120 | Tubular atrophy (HP:0000092) | 2.10576679 |
| 121 | Short 1st metacarpal (HP:0010034) | 2.10409384 |
| 122 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.10409384 |
| 123 | Hypotension (HP:0002615) | 2.10359432 |
| 124 | Polycythemia (HP:0001901) | 2.09671311 |
| 125 | Hyperphosphatemia (HP:0002905) | 2.09414090 |
| 126 | Abnormal blistering of the skin (HP:0008066) | 2.09260855 |
| 127 | Congenital sensorineural hearing impairment (HP:0008527) | 2.08711652 |
| 128 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.07874399 |
| 129 | Patent foramen ovale (HP:0001655) | 2.06990773 |
| 130 | Vacuolated lymphocytes (HP:0001922) | 2.06482054 |
| 131 | Abnormality of glycine metabolism (HP:0010895) | 2.05078600 |
| 132 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.05078600 |
| 133 | Esophageal varix (HP:0002040) | 2.04340342 |
| 134 | Hypoplasia of the odontoid process (HP:0003311) | 2.02021329 |
| 135 | Sensorimotor neuropathy (HP:0007141) | 2.01378268 |
| 136 | Xanthomatosis (HP:0000991) | 2.00913109 |
| 137 | Muscle fiber splitting (HP:0003555) | 2.00623499 |
| 138 | Abnormality of vitamin metabolism (HP:0100508) | 2.00375552 |
| 139 | Abnormality of the renal cortex (HP:0011035) | 1.99323993 |
| 140 | Hypoglycemic seizures (HP:0002173) | 1.98049840 |
| 141 | Nail dystrophy (HP:0008404) | 1.97615890 |
| 142 | Decreased circulating renin level (HP:0003351) | 1.97588532 |
| 143 | Hyperparathyroidism (HP:0000843) | 1.97392230 |
| 144 | Aplasia of the musculature (HP:0100854) | 1.97054369 |
| 145 | Alkalosis (HP:0001948) | 1.96483229 |
| 146 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.96339984 |
| 147 | Abnormality of the 2nd finger (HP:0004100) | 1.95776063 |
| 148 | Focal segmental glomerulosclerosis (HP:0000097) | 1.95177835 |
| 149 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95008388 |
| 150 | Mucopolysacchariduria (HP:0008155) | 1.95008388 |
| 151 | Widely patent fontanelles and sutures (HP:0004492) | 1.91998266 |
| 152 | Confusion (HP:0001289) | 1.91607893 |
| 153 | Abnormal trabecular bone morphology (HP:0100671) | 1.90480645 |
| 154 | Ventricular fibrillation (HP:0001663) | 1.90214821 |
| 155 | Hepatic necrosis (HP:0002605) | 1.89384486 |
| 156 | Abnormality of the vocal cords (HP:0008777) | 1.88390495 |
| 157 | Rectal prolapse (HP:0002035) | 1.88109153 |
| 158 | Abnormal vertebral ossification (HP:0100569) | 1.87945449 |
| 159 | Fetal akinesia sequence (HP:0001989) | 1.85780711 |
| 160 | Cone-rod dystrophy (HP:0000548) | 1.85620928 |
| 161 | Thyroiditis (HP:0100646) | 1.84786829 |
| 162 | Obstructive sleep apnea (HP:0002870) | 1.82846564 |
| 163 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82645550 |
| 164 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82645550 |
| 165 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82645550 |
| 166 | Sparse eyelashes (HP:0000653) | 1.81548216 |
| 167 | Rhabdomyolysis (HP:0003201) | 1.76514104 |
| 168 | Abnormality of renin-angiotensin system (HP:0000847) | 1.73049742 |
| 169 | Abnormality of macrophages (HP:0004311) | 1.70421281 |
| 170 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.70100567 |
| 171 | Epiphyseal dysplasia (HP:0002656) | 1.70024570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 5.83410870 |
| 2 | FRK | 5.66003385 |
| 3 | MST1R | 5.39094884 |
| 4 | EPHA2 | 4.78588359 |
| 5 | STK39 | 3.39009094 |
| 6 | NME1 | 3.16691188 |
| 7 | LMTK2 | 2.94300277 |
| 8 | MAP2K2 | 2.87581649 |
| 9 | RIPK1 | 2.55210597 |
| 10 | OXSR1 | 2.49877244 |
| 11 | GRK6 | 2.29212555 |
| 12 | PRKG2 | 2.27368221 |
| 13 | ZAP70 | 2.22897234 |
| 14 | PTK6 | 2.12154978 |
| 15 | TESK1 | 2.07340208 |
| 16 | KSR2 | 1.96317418 |
| 17 | MAP3K2 | 1.93869564 |
| 18 | MET | 1.93500406 |
| 19 | EPHB2 | 1.77043712 |
| 20 | VRK2 | 1.74876440 |
| 21 | ERN1 | 1.74339651 |
| 22 | ERBB4 | 1.66715239 |
| 23 | TAOK1 | 1.57403968 |
| 24 | PIK3CA | 1.56547458 |
| 25 | TNIK | 1.50042935 |
| 26 | INSRR | 1.45983131 |
| 27 | AKT3 | 1.41824212 |
| 28 | TESK2 | 1.40444929 |
| 29 | STK10 | 1.39761184 |
| 30 | MAP2K1 | 1.36308069 |
| 31 | MAP3K10 | 1.31821407 |
| 32 | FER | 1.31131758 |
| 33 | MAP3K12 | 1.24001364 |
| 34 | NLK | 1.23815899 |
| 35 | PRKCI | 1.23204199 |
| 36 | PTK2 | 1.22327141 |
| 37 | PAK4 | 1.21520597 |
| 38 | EPHB1 | 1.18552308 |
| 39 | GRK1 | 1.18104943 |
| 40 | TGFBR2 | 1.16170773 |
| 41 | ACVR1B | 1.14831204 |
| 42 | MAP3K9 | 1.10098043 |
| 43 | LATS1 | 1.08641785 |
| 44 | MYLK | 1.08107937 |
| 45 | RIPK4 | 1.05763309 |
| 46 | MAP3K1 | 1.04072197 |
| 47 | LIMK1 | 1.03313739 |
| 48 | MAP2K6 | 0.94681980 |
| 49 | MAP3K11 | 0.91696277 |
| 50 | BMX | 0.89279255 |
| 51 | DMPK | 0.86757150 |
| 52 | TTK | 0.86614667 |
| 53 | MAP3K8 | 0.86518709 |
| 54 | MAPK7 | 0.84522919 |
| 55 | DDR2 | 0.84454254 |
| 56 | NUAK1 | 0.84415871 |
| 57 | IKBKB | 0.79887071 |
| 58 | DAPK1 | 0.79167708 |
| 59 | ERBB2 | 0.78448712 |
| 60 | IKBKE | 0.76033512 |
| 61 | PAK3 | 0.70376252 |
| 62 | LRRK2 | 0.67015972 |
| 63 | MAP3K14 | 0.66549855 |
| 64 | JAK1 | 0.65765489 |
| 65 | CDC42BPA | 0.65717341 |
| 66 | PRKAA2 | 0.65477663 |
| 67 | FGFR3 | 0.63494100 |
| 68 | PDGFRB | 0.61684665 |
| 69 | MATK | 0.61403050 |
| 70 | TAOK3 | 0.60438387 |
| 71 | MAP3K7 | 0.59871303 |
| 72 | EEF2K | 0.57915150 |
| 73 | TNK2 | 0.56284818 |
| 74 | PRKCQ | 0.54904049 |
| 75 | MAPK11 | 0.54573510 |
| 76 | CAMK2D | 0.54306361 |
| 77 | IRAK1 | 0.53377281 |
| 78 | PIM2 | 0.52882501 |
| 79 | CLK1 | 0.52822512 |
| 80 | MAP3K3 | 0.51577988 |
| 81 | KSR1 | 0.49890004 |
| 82 | TBK1 | 0.49039388 |
| 83 | LATS2 | 0.48208798 |
| 84 | PDPK1 | 0.47631142 |
| 85 | TYK2 | 0.47626790 |
| 86 | IGF1R | 0.46511402 |
| 87 | PAK1 | 0.44167905 |
| 88 | PBK | 0.42505957 |
| 89 | ILK | 0.42169839 |
| 90 | TRIB3 | 0.41088798 |
| 91 | STK3 | 0.40442108 |
| 92 | PKN2 | 0.39799834 |
| 93 | TIE1 | 0.39708155 |
| 94 | AURKB | 0.38908199 |
| 95 | DAPK2 | 0.38859186 |
| 96 | PRKCE | 0.38756293 |
| 97 | PHKG2 | 0.38642366 |
| 98 | PHKG1 | 0.38642366 |
| 99 | EPHA3 | 0.38046900 |
| 100 | MAPKAPK3 | 0.36306073 |
| 101 | CAMK2G | 0.35963098 |
| 102 | ADRBK2 | 0.35821600 |
| 103 | SRC | 0.35786114 |
| 104 | MAP3K6 | 0.33492713 |
| 105 | STK16 | 0.33279902 |
| 106 | PIK3CG | 0.32191740 |
| 107 | CAMK2B | 0.31222137 |
| 108 | ARAF | 0.31179834 |
| 109 | PRKAA1 | 0.30618508 |
| 110 | CDK6 | 0.29927419 |
| 111 | RAF1 | 0.29339209 |
| 112 | MAP3K13 | 0.29236247 |
| 113 | JAK3 | 0.29163702 |
| 114 | PRKCA | 0.28978597 |
| 115 | FES | 0.27891096 |
| 116 | MELK | 0.27498410 |
| 117 | MAPKAPK2 | 0.27449952 |
| 118 | PDK1 | 0.27248902 |
| 119 | BMPR1B | 0.26652473 |
| 120 | TYRO3 | 0.26623332 |
| 121 | DAPK3 | 0.26022656 |
| 122 | PRKACG | 0.23730523 |
| 123 | STK38L | 0.23472992 |
| 124 | BMPR2 | 0.23219622 |
| 125 | ICK | 0.23103703 |
| 126 | PDK2 | 0.22976409 |
| 127 | EGFR | 0.20935466 |
| 128 | JAK2 | 0.19833679 |
| 129 | ROCK1 | 0.19650626 |
| 130 | PRPF4B | 0.19540032 |
| 131 | CHUK | 0.19128877 |
| 132 | CSK | 0.18549776 |
| 133 | RPS6KB2 | 0.18474168 |
| 134 | STK24 | 0.18126441 |
| 135 | CSNK1A1 | 0.18006388 |
| 136 | FGR | 0.17756600 |
| 137 | IRAK4 | 0.17685678 |
| 138 | PRKCD | 0.17485667 |
| 139 | MAP3K5 | 0.16445453 |
| 140 | SGK1 | 0.16043435 |
| 141 | SCYL2 | 0.15706961 |
| 142 | HIPK2 | 0.15343480 |
| 143 | RET | 0.13697571 |
| 144 | FYN | 0.13170012 |
| 145 | FGFR4 | 0.11984572 |
| 146 | ABL2 | 0.11359588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 5.78481341 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.74953926 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 4.26215303 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.92412791 |
| 5 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.77700612 |
| 6 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.99134625 |
| 7 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.88009722 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.55825117 |
| 9 | Bile secretion_Homo sapiens_hsa04976 | 2.42023066 |
| 10 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.33878221 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.31273708 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.10279013 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.08071225 |
| 14 | Galactose metabolism_Homo sapiens_hsa00052 | 1.97611963 |
| 15 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.96956165 |
| 16 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.92189798 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80411076 |
| 18 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.72173116 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67103723 |
| 20 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.65584397 |
| 21 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.60051627 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.54062777 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.49965143 |
| 24 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.48187076 |
| 25 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.45302378 |
| 26 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.44878568 |
| 27 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.40903692 |
| 28 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.36987853 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.36476083 |
| 30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.33951812 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32836345 |
| 32 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.23495528 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.20607501 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.18740674 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.15686188 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.11905288 |
| 37 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.07722363 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04034211 |
| 39 | Tight junction_Homo sapiens_hsa04530 | 1.00304408 |
| 40 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.98955953 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96722613 |
| 42 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.96640625 |
| 43 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.95922655 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.95922452 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95186041 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93300233 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89961028 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89185632 |
| 49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83767572 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.79621090 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79248732 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.76358785 |
| 53 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.75574333 |
| 54 | Peroxisome_Homo sapiens_hsa04146 | 0.75549006 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73805196 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.73600304 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 0.72882102 |
| 58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72504462 |
| 59 | Asthma_Homo sapiens_hsa05310 | 0.70134705 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.69469107 |
| 61 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67801979 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67488928 |
| 63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.65634748 |
| 64 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64445363 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.64420786 |
| 66 | Bladder cancer_Homo sapiens_hsa05219 | 0.62333908 |
| 67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61843882 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61596753 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60878542 |
| 70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58608515 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58349698 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57675735 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54309708 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.53952819 |
| 75 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.53455587 |
| 76 | Adherens junction_Homo sapiens_hsa04520 | 0.51494778 |
| 77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50656061 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48674163 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.48563732 |
| 80 | ABC transporters_Homo sapiens_hsa02010 | 0.48539833 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.45061635 |
| 82 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.44984831 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.42065476 |
| 84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41391230 |
| 85 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.41139056 |
| 86 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41130101 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40333068 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40167433 |
| 89 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.39990925 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39444452 |
| 91 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39158255 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.38492685 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37803821 |
| 94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37677641 |
| 95 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37256047 |
| 96 | Legionellosis_Homo sapiens_hsa05134 | 0.37028686 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36122893 |
| 98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35156882 |
| 99 | Pertussis_Homo sapiens_hsa05133 | 0.32651339 |
| 100 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.32567052 |
| 101 | Long-term depression_Homo sapiens_hsa04730 | 0.31048656 |
| 102 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.28770395 |
| 103 | Allograft rejection_Homo sapiens_hsa05330 | 0.28561916 |
| 104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.28125915 |
| 105 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.27129050 |
| 106 | Retinol metabolism_Homo sapiens_hsa00830 | 0.24240014 |
| 107 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.23091155 |
| 108 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.22655133 |
| 109 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.20165643 |
| 110 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.19931464 |
| 111 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.19741144 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.18139331 |
| 113 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.18033476 |
| 114 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.17506605 |
| 115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.17236389 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.16712084 |
| 117 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.16425978 |
| 118 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.16011049 |
| 119 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.15729861 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.15415138 |
| 121 | Shigellosis_Homo sapiens_hsa05131 | 0.15247199 |
| 122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.14956803 |
| 123 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.14781206 |
| 124 | Influenza A_Homo sapiens_hsa05164 | 0.14503718 |
| 125 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.14419463 |
| 126 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.12444538 |
| 127 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.11783908 |
| 128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.10612067 |
| 129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.10361562 |
| 130 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.09776381 |
| 131 | Leishmaniasis_Homo sapiens_hsa05140 | 0.09430536 |

